| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1016/J.CJCA.2012.12.003 |
| P953 | full work available online at | https://api.elsevier.com/content/article/PII:S0828282X12015152?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0828282X12015152?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 23465346 |
| P2093 | author name string | Hong Wang | |
| Na Li | |||
| Qian Zhang | |||
| Chen Jin | |||
| Yue-Jin Yang | |||
| Hai-Yan Qian | |||
| P2860 | cites work | Positive shifts in the perceived meaning of cardiac pain following a psychoeducation program for chronic stable angina | Q50892646 |
| Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial | Q50981942 | ||
| Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. | Q53255488 | ||
| Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. | Q53292806 | ||
| Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). | Q53455003 | ||
| Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction | Q53570839 | ||
| Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. | Q53643417 | ||
| Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium | Q57744067 | ||
| Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled | Q59260969 | ||
| CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells | Q79317344 | ||
| Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo | Q81134098 | ||
| Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease | Q82727493 | ||
| Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia | Q83089220 | ||
| Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function | Q83135462 | ||
| Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction | Q28248284 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. | Q30444845 | ||
| Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation | Q33202256 | ||
| Improvement of myocardial perfusion reserve detected by cardiovascular magnetic resonance after direct endomyocardial implantation of autologous bone marrow cells in patients with severe coronary artery disease | Q33753521 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population | Q34498277 | ||
| The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina | Q34532401 | ||
| Adult stem cell therapy in perspective | Q35071546 | ||
| Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina | Q35308043 | ||
| Human embryonic stem cell transplantation to repair the infarcted myocardium | Q36025653 | ||
| Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies | Q37092349 | ||
| Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues | Q37092351 | ||
| Women and ischemic heart disease: evolving knowledge. | Q37462134 | ||
| Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease | Q37901551 | ||
| Oncogenic challenges in stem cells and the link to cancer initiation | Q37988756 | ||
| Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial | Q38381605 | ||
| Management of Patients With Refractory Angina: Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines | Q39639358 | ||
| Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 | ||
| Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation | Q40611732 | ||
| Intracoronary autologous CD34+ stem cell therapy for intractable angina | Q42848065 | ||
| Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study | Q44115463 | ||
| Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction | Q44201662 | ||
| Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium | Q46057122 | ||
| Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 | ||
| Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction | Q48619654 | ||
| Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function | Q50774320 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 908-914 | |
| P577 | publication date | 2013-03-05 | |
| P1433 | published in | The Canadian Journal of Cardiology | Q3502278 |
| P1476 | title | Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials | |
| Stem Cell Therapy Is a Promising Tool for Refractory Angina: A Meta-analysis of Randomized Controlled Trials | |||
| P478 | volume | 29 |
| Q47190217 | Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials |
| Q39790202 | Autologous CD34+ Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study |
| Q43092460 | Can endothelial progenitor cells treat patients with refractory angina? |
| Q42343993 | Cell Therapy Augments Myocardial Perfusion and Improves Quality of Life in Patients With Refractory Angina. |
| Q48155875 | Cell Therapy for Refractory Angina: A Reappraisal. |
| Q38226693 | Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences. |
| Q38267714 | Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions |
| Q38697092 | Current State of Stem Cell Therapy for Ischemic Heart Disease |
| Q30729604 | Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis |
| Q58741622 | Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO) |
| Q92218851 | Management of Refractory Angina Pectoris |
| Q55649548 | Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina. |
| Q57495833 | New Advances in the Management of Refractory Angina Pectoris |
| Q45718133 | Nothing Refractory About Cardiac Cell Therapy |
| Q38579533 | Pharmacological and emerging therapies in the treatment of chronic angina |
| Q38262671 | Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications |
| Q46102792 | The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. |
| Q38173640 | Treatment of refractory angina in patients not suitable for revascularization |
Search more.